Format

Send to

Choose Destination
See comment in PubMed Commons below
AIDS Rev. 2002 Jul-Sep;4(3):119-27.

Dynamics and evolution of HIV-1 during structured treatment interruptions.

Author information

1
Department of Pathology, School of Medicine, University of California, San Diego, USA. sdfrost@ucsd.edu

Abstract

Our understanding of the way in which HIV responds to highly active antiretroviral therapy (HAART) has benefited greatly from the use of mathematical models of viral dynamics and evolution. In this paper, I review the role that these models may play in the design and analysis of studies of structured treatment interruptions (STIs). STIs are being investigated in several different contexts: to reduce drug toxicities; to boost HIV-specific immune responses; and to allow reversion of drug resistance mutations in highly drug-experienced patients. I illustrate how models can help to compare the dynamics and evolution of HIV in these different scenarios, and to assess the risks and benefits of STIs.

PMID:
12416446
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center